Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumors face NO problems?

Jack R Lancaster1, Keping Xie

  • 1Center for Free Radical Biology, Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, AL, USA.

Cancer Research
|July 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Up-regulated IL-36 expression promotes a pro-tumorigenic phenotype in pancreatic ductal adenocarcinoma.

Genes & diseases·2026
Same author

Ganglioside-Mediated Neural-Acinar Crosstalk Facilitates Pancreatic Carcinogenesis via Metaplastic Niche Remodeling.

Gastroenterology·2026
Same author

OSBPL3-driven sterol metabolic reprogramming promotes oncogenic signaling and therapeutic resistance in pancreatic cancer.

Theranostics·2026
Same author

Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy.

Genes & diseases·2026
Same author

Transcriptional deregulation by FOXM1-JUP signaling confers dual oncogenic drivers for pancreatic tumorigenesis and therapeutic resistance.

Cell communication and signaling : CCS·2025
Same author

Plakophilin 3 drives acinar cell transformation and promotes cancer initiation and progression in pancreas.

Cell reports·2025
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Nitric oxide synthase II (NOS II) has paradoxical effects in cancer biology. This study explores variability in NO production, chemistry, and cellular responses to explain these dual actions, highlighting cellular adaptation to NO's cytotoxic effects.

Area of Science:

  • Molecular biology
  • Cancer research
  • Biochemistry

Background:

  • The role of inducible nitric oxide synthase (NOS II) in cancer remains controversial, with studies reporting both pro- and anti-tumorigenic effects.
  • Understanding the factors contributing to these contradictory observations is crucial for advancing cancer therapy.

Purpose of the Study:

  • To elucidate the complex and often paradoxical effects of NOS II expression on cancer biology.
  • To identify key factors influencing the dual role of nitric oxide (NO) in the tumor microenvironment.

Main Methods:

  • Analysis of factors contributing to paradoxical NO actions, including NO production variability.
  • Investigation of NO chemistry heterogeneity and its impact on cellular functions.
  • Examination of differential cellular responses to NO.

Related Experiment Videos

  • Assessment of cellular adaptation and selection under cytotoxic NO pressure.

    • Main Results:

    • Paradoxical effects of NOS II in cancer stem from variations in NO production levels.
    • Heterogeneity in NO's chemical reactivity leads to diverse cellular outcomes.
    • Differential cellular sensitivity and adaptive responses to NO significantly modulate its biological impact.
    • Cellular adaptation and selection to NO's cytotoxic effects are major determinants of cancer progression or suppression.

    Conclusions:

    • The dual role of NOS II in cancer is explained by multifactorial influences including NO production, chemistry, and cellular responses.
    • Cellular adaptation and selection to NO cytotoxicity are critical determinants of cancer biology outcomes.
    • Further research into these factors may reveal novel therapeutic strategies targeting NO pathways in cancer.